Sahajanand Medical Technologies Earns EU MDR Certification for Supraflex Cruz Stent
Sahajanand Medical Technologies Limited (SMT) has received certification under the European Union Medical Device Regulation (EU MDR 2017/745) for its Supraflex Cruz coronary stent and related products. This certification confirms compliance with stringent EU safety, performance, and clinical evidence standards. Supraflex Cruz, a sirolimus-eluting stent, has treated over 2.5 million patients in more than 75 countries, supported by extensive clinical trials and registries. SMT is a leading manufacturer in India's drug-eluting stent market and ranks among the top five in key European countries.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (76/100). Lens Score 34/100.
Outlets measured: thehindu, thetribune. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (75–78/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
thetribune broke this story on 24 Sept, 11:49 am. Other outlets followed.